18.8
Ernexa Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
13.7
FY23:
9.60
FY24:
2.35
FY25:
3.13
(positive)
Change from FY21 to FY25
millions USD
FY21:
12.8
FY22:
8.60
FY23:
39.5
FY24:
2.92
FY25:
2.70
Total assets
Change from FY21 to FY25
millions USD
FY21:
31.5
FY22:
22.3
FY23:
49.1
FY24:
5.27
FY25:
5.83
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.68
FY22:
7.65
FY23:
6.57
FY24:
2.94
FY25:
3.11
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.35
FY22:
2.52
FY23:
40.3
FY24:
0.63
FY25:
0.32
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.5
FY22:
12.1
FY23:
2.23
FY24:
1.70
FY25:
2.40
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
31.5
FY22:
22.3
FY23:
49.1
FY24:
5.27
FY25:
5.83
All amounts in millions USD